Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
M. Reza Razeghinejad. (2019) The Effect of Latanaprost on Intraocular Inflammation and Macular Edema. Ocular Immunology and Inflammation 27:2, pages 181-188.
Read now
Read now
Douglas A Katsev, Cailyn C Katsev, Jen Pinnow & Catherine M Lockhart. (2017) Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration. Clinical Ophthalmology 11, pages 1897-1901.
Read now
Read now
Huba J. Kiss, Agnes I. Takacs, Kinga Kranitz, Gabor L. Sandor, Gabor Toth, Beatrix Gilanyi & Zoltan Z. Nagy. (2016) One-Day Use of Preoperative Topical Nonsteroidal Anti-Inflammatory Drug Prevents Intraoperative Prostaglandin Level Elevation During Femtosecond Laser-Assisted Cataract Surgery. Current Eye Research 41:8, pages 1064-1067.
Read now
Read now
Robert H Osher, Iqbal Ike K Ahmed & Gregory A Demopulos. (2015) OMS302 (phenylephrine and ketorolac injection) 1%/0.3% to maintain intraoperative pupil size and to prevent postoperative ocular pain in cataract surgery with intraocular lens replacement. Expert Review of Ophthalmology 10:2, pages 91-103.
Read now
Read now
Eric D Donnenfeld. (2015) Current trends in postsurgical management of ocular inflammation following cataract surgery. Expert Review of Ophthalmology 10:1, pages 23-31.
Read now
Read now
Rajesh K Rajpal, Bryan Ross, Sachin D Rajpal & Khoa Hoang. (2014) Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence. Patient Preference and Adherence 8, pages 925-931.
Read now
Read now
George A Baklayan & Mauricio Muñoz. (2014) The ocular distribution of 14C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model. Clinical Ophthalmology 8, pages 1717-1724.
Read now
Read now
Steven M Silverstein, Mitchell A Jackson, Damien F Goldberg & Mauricio Muñoz. (2014) The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery. Clinical Ophthalmology 8, pages 965-972.
Read now
Read now
Seanna R Grob, Luis A Gonzalez-Gonzalez & Mary K Daly. (2014) Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions. Clinical Ophthalmology 8, pages 1281-1289.
Read now
Read now
Nour Maya N. Haddad, Jennifer K. Sun, Samer Abujaber, Deborah K. Schlossman & Paolo S. Silva. (2014) Cataract Surgery and its Complications in Diabetic Patients. Seminars in Ophthalmology 29:5-6, pages 329-337.
Read now
Read now
Melissa Cable. (2012) Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site. Clinical Ophthalmology 6, pages 997-1004.
Read now
Read now
Rishi Singh, Louis Alpern, Glenn J Jaffe, Robert P Lehmann, John Lim, Harvey J Reiser, Kenneth Sall, Thomas Walters & Dana Sager. (2012) Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology 6, pages 1259-1269.
Read now
Read now
Kemal Örnek & Zafer Onaran. (2012) Refractory cystoid macular oedema due to intraocular lens haptic perforating the iris. Clinical and Experimental Optometry 95:5, pages 553-554.
Read now
Read now
Keping Xu, Mark McDermott, Linda Villanueva, Rhett M Schiffman & David A Hollander. (2011) Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs. Clinical Ophthalmology 5, pages 269-274.
Read now
Read now
Maaly A. Halim Mohamed & Azza A. Mahmoud. (2011) Formulation of Indomethacin Eye Drops via Complexation with Cyclodextrins. Current Eye Research 36:3, pages 208-216.
Read now
Read now
Eliana B. Souto, Slavomira Doktorovova, Elisabet Gonzalez-Mira, Maria Antonia Egea & Maria Luisa Garcia. (2010) Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs. Current Eye Research 35:7, pages 537-552.
Read now
Read now
Hyung Cho, Kenneth J Wolf & Eric J Wolf. (2009) Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clinical Ophthalmology 3, pages 199-210.
Read now
Read now
Seenu M Hariprasad, Levent Akduman, Joseph A Clever, Michael Ober, Franco M Recchia & William F Mieler. (2009) Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Clinical Ophthalmology 3, pages 147-154.
Read now
Read now
Hyung Cho & Assumpta Madu. (2009) Etiology and treatment of the inflammatory causes of cystoid macular edema. Journal of Inflammation Research 2, pages 37-43.
Read now
Read now
Henry D Perry & Eric D Donnenfeld. (2008) Bromfenac ophthalmic solution 0.09%: ocular role and systemic safety profile. Expert Review of Ophthalmology 3:2, pages 121-129.
Read now
Read now
M Nardi, C Lobo, A Bereczki, J Cano, E Zagato, S Potts, G Sullins & R Notivol. (2007) Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery. Clinical Ophthalmology 1:4, pages 527-533.
Read now
Read now
Michael B. Raizman, Eric D. Donnenfeld & Arthur J. Weinstein. (2007) Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. Current Medical Research and Opinion 23:10, pages 2325-2331.
Read now
Read now
Richard Lindstrom & Terry Kim. (2006) Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Current Medical Research and Opinion 22:2, pages 397-404.
Read now
Read now
Henry D Perry & Eric D Donnenfeld. (2006) An update on the use of ophthalmic ketorolac tromethamine 0.4%. Expert Opinion on Pharmacotherapy 7:1, pages 99-107.
Read now
Read now
Articles from other publishers (67)
Jee Hyun Jeong, Kyung Tae Kang, You Hyun Lee & Yu Cheol Kim. (2023) Correlation between Severity of Idiopathic Epiretinal Membrane and Irvine–Gass Syndrome. Journal of Personalized Medicine 13:9, pages 1341.
Crossref
Crossref
Lăcrămioara Samoilă, Oliviu Voștinaru, Elena Dinte, Andreea Elena Bodoki, Bogdan-Cezar Iacob, Ede Bodoki & Ovidiu Samoilă. (2023) Topical Treatment for Retinal Degenerative Pathologies: A Systematic Review. International Journal of Molecular Sciences 24:9, pages 8045.
Crossref
Crossref
Hasan Razmjoo, Mohammad Mikaniki, Alireza Peyman, Ebrahim Mikaniki, Mahdi Abounoori & Mohsen Pourazizi. (2022) Clinical efficacy of Fluorometholone versus Loteprednol eye drops after photorefractive keratectomy: A triple-blinded randomized controlled trial. European Journal of Ophthalmology 33:1, pages 595-601.
Crossref
Crossref
Seonjoo Kim, Byung-Yi Ko, Jae Woong Koh, Eun Chul Kim, Hong Kyun Kim, Young Joo Shin, Jong-Suk Song, Do Hyung Lee, Ji Eun Lee, Hyung Keun Lee, So-Hyang Chung & Hyun Seung Kim. (2022) Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial. Journal of Cataract and Refractive Surgery 48:6, pages 710-716.
Crossref
Crossref
Sherif A. Gaballa, Uday B. Kompella, Omar Elgarhy, Ali M. Alqahtani, Barbara Pierscionek, Raid G. Alany & Hamdy Abdelkader. (2020) Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Delivery and Translational Research 11:3, pages 866-893.
Crossref
Crossref
斌 韦. (2021) Clinical Research of Intravitreal Triamcinolone Acetonide for Refractory Chronic Pseudophakic Cystoid Macular Edema. Hans Journal of Ophthalmology 10:02, pages 64-68.
Crossref
Crossref
Mehrdad Mohammadpour, Siamak Maleki & Masoud Khorrami-Nejad. (2019) The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery: A randomized clinical trial. European Journal of Ophthalmology 30:6, pages 1314-1319.
Crossref
Crossref
Ana Topete, Junmei Tang, Xiaoxu Ding, Helena P. Filipe, Jorge A. Saraiva, Ana Paula Serro, Quankui Lin & Benilde Saramago. (2020) Dual drug delivery from hydrophobic and hydrophilic intraocular lenses: in-vitro and in-vivo studies. Journal of Controlled Release 326, pages 245-255.
Crossref
Crossref
Mehmed Uğur Işık & Nilüfer F. Yalçındağ. (2020) Comparison of the efficacy of nepafenac 0.1% in quiescent Behçet’s uveitis and non-uveitic healthy patients after phacoemulsification surgery. International Ophthalmology 40:9, pages 2345-2351.
Crossref
Crossref
Steven M. Silverstein. (2019) Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose. Ophthalmology and Therapy 8:4, pages 577-587.
Crossref
Crossref
Andreia F.R. Pimenta, Ana Paula Serro, Rogério Colaço & Anuj Chauhan. (2019) Optimization of intraocular lens hydrogels for dual drug release: Experimentation and modelling. European Journal of Pharmaceutics and Biopharmaceutics 141, pages 51-57.
Crossref
Crossref
Ahmed Alnagdy, Ahmed M. Eissa & Amr El-Kannishy. 2019. Frontiers in Ophthalmology and Ocular Imaging. Frontiers in Ophthalmology and Ocular Imaging.
Ana Topete, A.P. Serro & B. Saramago. (2019) Dual drug delivery from intraocular lens material for prophylaxis of endophthalmitis in cataract surgery. International Journal of Pharmaceutics 558, pages 43-52.
Crossref
Crossref
John Hovanesian & Edward Holland. (2019) Tolerability and toxicity of topically applied nepafenac 0.3% compared with generic ketorolac 0.5%. Journal of Cataract and Refractive Surgery 45:2, pages 174-180.
Crossref
Crossref
T. N. Safonova & N. P. Kintyukhina. (2019) Effectiveness of a nonsteroidal anti-inflammatory drug in the treatment of chronic non-infectious blepharitis. Vestnik oftal'mologii 135:6, pages 73.
Crossref
Crossref
I. E. Ioshin, A. I. Tolchinskaya & A. M. Bagirov. (2019) Treatment of postoperative macular edema (a clinical case study). Vestnik oftal'mologii 135:3, pages 90.
Crossref
Crossref
Ana Topete, Andreia S. Oliveira, A. Fernandes, T.G. Nunes, A.P. Serro & B. Saramago. (2018) Improving sustained drug delivery from ophthalmic lens materials through the control of temperature and time of loading. European Journal of Pharmaceutical Sciences 117, pages 107-117.
Crossref
Crossref
I. E. Ioshin, A. I. Tolchinskaya & A. M. Bagirov. (2018) Treatment of postoperative macular edema (a clinical case study). Vestnik oftal'mologii 134:3, pages 99.
Crossref
Crossref
Hsien-Yin Liao, Ching-Liang Hsieh, Chun-Ping Huang & Yi-Wen Lin. (2017) Electroacupuncture Attenuates Induction of Inflammatory Pain by Regulating Opioid and Adenosine Pathways in Mice. Scientific Reports 7:1.
Crossref
Crossref
Hui ChenHaotian LinWan ChenBo ZhangWu XiangJing LiWeirong Chen. (2017)
Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E
2
Inhibition in Femtosecond Laser-Assisted Cataract Surgery
. Journal of Ocular Pharmacology and Therapeutics 33:3, pages 193-201.
Crossref
Crossref
Xinyu Zhao, Song Xia, Erqian Wang & Youxin Chen. (2017) Comparison of the efficacy and patients’ tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials. PLOS ONE 12:3, pages e0173254.
Crossref
Crossref
Morteza Entezari, Alireza Ramezani, Homayon Nikkhah & Mehdi Yaseri. (2016) The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology 37:1, pages 13-18.
Crossref
Crossref
Seonghwan KimMee Kum KimWon Ryang Wee. (2017) Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane. Korean Journal of Ophthalmology 31:5, pages 394.
Crossref
Crossref
Shihui Yu, Guoxin Tan, Dandan Liu, Xinggang Yang & Weisan Pan. (2017) Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies. RSC Advances 7:27, pages 16668-16677.
Crossref
Crossref
Richard S. Hoffman, Rosa Braga-Mele, Kendall Donaldson, Geoffrey Emerick, Bonnie Henderson, Malik Kahook, Nick Mamalis, Kevin M. Miller, Tony Realini, Neal H. Shorstein, Richard K. Stiverson & Barbara Wirostko. (2016) Cataract surgery and nonsteroidal antiinflammatory drugs. Journal of Cataract and Refractive Surgery 42:9, pages 1368-1379.
Crossref
Crossref
Hyun Kyo JeongWoo Beom ShinKyoung Yul SeoJeihoon Lee. (2016) Comparison of 1% Prednisolone and 0.1% Bromfenac Solutions for Preventing Macular Edema after Cataract Surgery. Journal of the Korean Ophthalmological Society 57:12, pages 1834.
Crossref
Crossref
Alexander Parra, Mireia Mallandrich, Beatriz Clares, María A. Egea, Marta Espina, María L. García & Ana C. Calpena. (2015) Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications. Colloids and Surfaces B: Biointerfaces 136, pages 935-943.
Crossref
Crossref
Stephen J. Kim, Scott D. Schoenberger, Jennifer E. Thorne, Justis P. Ehlers, Steven Yeh & Sophie J. Bakri. (2015) Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery. Ophthalmology 122:11, pages 2159-2168.
Crossref
Crossref
M-Z Zhai, H-H Wu, J-J Li, L-P Jiang, Z-S Gao, W Hu, Y Liu & Y-T Wang. (2015) Topical bromfenac for post-cataract extraction: A systematic review and pooled analysis. European Journal of Inflammation 13:2, pages 130-135.
Crossref
Crossref
Chandra Sekhar G, Rama Mohan Pathapati, Varalakshmi U, Sarvepalli Skanda Harshita, Rajkumar Patra, Praneet Praneet, Madhavulu Madhavulu & Divyalasya T V S. (2015) HEAD - TO - HEAD COMPARISON OF TOLERABILITY AND ACCEPTABILITY OF SINGLE DOSE OF FOUR TOPICAL NSAIDS IN PATIENTS UNDERGOING CATARACT SURGERY : A RANDOMIZED OPEN LABEL PARALLEL GROUP STUDY. Journal of Evidence Based Medicine and Healthcare 2:31, pages 4568-4573.
Crossref
Crossref
Suqin Guo, Shriji Patel, Ben Baumrind, Keegan Johnson, Daniel Levinsohn, Edward Marcus, Brad Tannen, Monique Roy, Neelakshi Bhagat & Marco Zarbin. (2015) Management of pseudophakic cystoid macular edema. Survey of Ophthalmology 60:2, pages 123-137.
Crossref
Crossref
Jin Pyo Hong, Sang Min Nam, Chan Young Im, Sangchul Yoon, Tae-im Kim, Eung Kweon Kim & Kyoung Yul Seo. (2014) Comparison of analgesic effect of preoperative topical diclofenac and ketorolac on postoperative pain after photorefractive keratectomy. Journal of Cataract & Refractive Surgery 40:10, pages 1689-1696.
Crossref
Crossref
Thomas R. Walters, Damien F. Goldberg, James H. Peace & James A. Gow. (2014) Bromfenac Ophthalmic Solution 0.07% Dosed Once Daily for Cataract Surgery. Ophthalmology 121:1, pages 25-33.
Crossref
Crossref
Joseph R. Zelefsky & Stephen A. Obstbaum. 2014. Clinical Glaucoma Care. Clinical Glaucoma Care
625
644
.
Qi-wei Wang, Ke Yao, Wen Xu, Pei-qing Chen, Xing-chao Shentu, Xin Xie, Yan Weng, Li Zhang, Chong-fei Jin, Wei Wu, Ya-nan Zhu & Yin-hui Yu. (2013) Bromfenac Sodium 0.1%, Fluorometholone 0.1% and Dexamethasone 0.1% for Control of Ocular Inflammation and Prevention of Cystoid Macular Edema after Phacoemulsification. Ophthalmologica 229:4, pages 187-194.
Crossref
Crossref
David R.P. Almeida, Zainab Khan, Lin Xing, Shahrukh N. Bakar, Karim Rahim, Todd Urton & Sherif R. El-Defrawy. (2012) Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract & Refractive Surgery 38:9, pages 1537-1543.
Crossref
Crossref
Conceição Lobo. (2012) Pseudophakic Cystoid Macular Edema. Ophthalmologica 227:2, pages 61-67.
Crossref
Crossref
Bonnie A. Henderson, Johnny L. Gayton, Simon P. Chandler, James A. Gow, Sharon M. Klier & Timothy R. McNamara. (2011) Safety and Efficacy of Bromfenac Ophthalmic Solution (Bromday) Dosed Once Daily for Postoperative Ocular Inflammation and Pain. Ophthalmology 118:11, pages 2120-2127.
Crossref
Crossref
Paul L. McCormack. (2011) Ketorolac 0.45% Ophthalmic Solution. Drugs & Aging 28:7, pages 583-589.
Crossref
Crossref
L. David WaterburyDanielle GalindoLinda VillanuevaCathy NguyenMilan PatelLisa BorbridgeMayssa AttarRhett M. SchiffmanDavid A. Hollander. (2011) Ocular Penetration and Anti-inflammatory Activity of Ketorolac 0.45% and Bromfenac 0.09% Against Lipopolysaccharide-Induced Inflammation. Journal of Ocular Pharmacology and Therapeutics 27:2, pages 173-178.
Crossref
Crossref
Se Kyung KimJin Pyo HongSang Min NamKyoung Yul Seo. (2011) Preemptive Analgesic Effect of Topical NSAIDS in Postoperative Pain Relief after LASEK. Journal of the Korean Ophthalmological Society 52:12, pages 1414.
Crossref
Crossref
KEITH A. WARREN, HASAN BAHRANI & JENNI E. FOX. (2010) NSAIDS IN COMBINATION THERAPY FOR THE TREATMENT OF CHRONIC PSEUDOPHAKIC CYSTOID MACULAR EDEMA. Retina 30:2, pages 260-266.
Crossref
Crossref
Bo Young ChunSu Yeon KangJong Suk SongHyo Myung Kim. (2010) Comparison of the Effects of Prophylactic Nonsteroidal Anti-inflammatory Drugs on Macular Edema After Cataract Surgery. Journal of the Korean Ophthalmological Society 51:7, pages 935.
Crossref
Crossref
Andreas Pollreisz & Ursula Schmidt-Erfurth. (2010) Diabetic Cataract—Pathogenesis, Epidemiology and Treatment. Journal of Ophthalmology 2010, pages 1-8.
Crossref
Crossref
K C Mathys & K L Cohen. (2009) Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye 24:1, pages 90-96.
Crossref
Crossref
Joseph R. Zelefsky & Stephen A. Obstbaum. 2010. The Glaucoma Book. The Glaucoma Book
889
903
.
Joana Araújo, Elisabet Gonzalez, Maria Antonia Egea, Marisa Luisa Garcia & Eliana B. Souto. (2009) Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 5:4, pages 394-401.
Crossref
Crossref
Carlos Buznego & William B Trattler. (2009) Presbyopia-correcting intraocular lenses. Current Opinion in Ophthalmology 20:1, pages 13-18.
Crossref
Crossref
W. Andrew MaxwellHarvey J. ReiserRobert H. StewartH. Dwight CavanaghThomas R. WaltersDana P. SagerPatricia A. Meuse. (2008) Nepafenac Dosing Frequency for Ocular Pain and Inflammation Associated with Cataract Surgery. Journal of Ocular Pharmacology and Therapeutics 24:6, pages 593-600.
Crossref
Crossref
Kensaku MiyakeTakahiro OgawaTetsuya TajikaJames A. GowTimothy R. McNamara. (2008) Ocular Pharmacokinetics of a Single Dose of Bromfenac Sodium Ophthalmic Solution 0.1% in Human Aqueous Humor. Journal of Ocular Pharmacology and Therapeutics 24:6, pages 573-578.
Crossref
Crossref
. (2008) Canadian Ophthalmological Society evidence-based clinical practice guidelines for cataract surgery in the adult eye. Canadian Journal of Ophthalmology 43, pages S7-S33.
Crossref
Crossref
John R. Wittpenn, Steven Silverstein, Jeffrey Heier, Kenneth R. Kenyon, John D. Hunkeler & Melissa Earl. (2008) A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery Patients. American Journal of Ophthalmology 146:4, pages 554-560.e1.
Crossref
Crossref
. (2008) Guide de pratique clinique factuelle de la Société canadienne d’ophtalmologie pour la chirurgie de la cataracte de l’œil adulte. Canadian Journal of Ophthalmology 43, pages S35-S57.
Crossref
Crossref
George A. BaklayanHal M. PattersonClara K. SongJames A. GowTimothy R. McNamara. (2008)
24-Hour Evaluation of the Ocular Distribution of
14
C-Labeled Bromfenac Following Topical Instillation into the Eyes of New Zealand White Rabbits
. Journal of Ocular Pharmacology and Therapeutics 24:4, pages 392-398.
Crossref
Crossref
. (2008) Effects of Topical Nepafenac on Corneal Epithelial Healing Time and Postoperative Pain After PRK: A Bilateral, Prospective, Randomized, Masked Trial. Journal of Refractive Surgery 24:4, pages 377-382.
Crossref
Crossref
Seenu M. Hariprasad & David Callanan. (2008) TOPICAL NEPAFENAC 0.1% FOR TREATMENT OF CHRONIC UVEITIC CYSTOID MACULAR EDEMA. RETINAL Cases & Brief Reports 2:4, pages 304-308.
Crossref
Crossref
Sayaka Asano, Kensaku Miyake, Ichiro Ota, Gentaro Sugita, Wataru Kimura, Yuji Sakka & Nobuyuki Yabe. (2008) Reducing angiographic cystoid macular edema and blood–aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation. Journal of Cataract & Refractive Surgery 34:1, pages 57-63.
Crossref
Crossref
Mark L Arey, Brian R Sullivan, Carol G Reinert & James P McCulley. (2007) Impaired Corneal Wound Healing Associated With Ketorolac 0.5% After Uncomplicated Extracapsular Cataract Extraction. Cornea 26:10, pages 1159-1164.
Crossref
Crossref
Seenu M. HariprasadDavid CallananSteven GaineyYu-Guang HeKeith Warren. (2007) Cystoid and Diabetic Macular Edema Treated with Nepafenac 0.1%. Journal of Ocular Pharmacology and Therapeutics 23:6, pages 585-590.
Crossref
Crossref
Eric J. Wolf, Alexandra Braunstein, Carolyn Shih & Richard E. Braunstein. (2007) Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. Journal of Cataract & Refractive Surgery 33:9, pages 1546-1549.
Crossref
Crossref
Tom Walters, Michael Raizman, Paul Ernest, Johnny Gayton & Robert Lehmann. (2007) In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. Journal of Cataract and Refractive Surgery 33:9, pages 1539-1545.
Crossref
Crossref
Bonnie A. Henderson, Jae Yong Kim, Christine S. Ament, Zandra K. Ferrufino-Ponce, Anna Grabowska & Sandra L. Cremers. (2007) Clinical pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery 33:9, pages 1550-1558.
Crossref
Crossref
Joseph Colin. (2007) The Role of NSAIDs in the Management of Postoperative Ophthalmic Inflammation. Drugs 67:9, pages 1291-1308.
Crossref
Crossref
Stephen S. Lane, Satish S. Modi, Robert P. Lehmann & Edward J. Holland. (2007) Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Journal of Cataract & Refractive Surgery 33:1, pages 53-58.
Crossref
Crossref
Eric D. Donnenfeld & Ashley Donnenfeld. (2006) Global Experience With Xibrom (Bromfenac Ophthalmic Solution) 0.09%: The First Twice-daily Ophthalmic Nonsteroidal Anti-inflammatory Drug. International Ophthalmology Clinics 46:4, pages 21-40.
Crossref
Crossref
Richard Lindstrom. (2006) The Pharmacologic and Pathophysiologic Rationale for Using NSAIDs in Ocular Inflammatory Disease and Ocular Surgery. International Ophthalmology Clinics 46:4, pages 7-11.
Crossref
Crossref
Stephen S. Lane. (2006) Nepafenac: A Unique Nonsteroidal Prodrug. International Ophthalmology Clinics 46:4, pages 13-20.
Crossref
Crossref